| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent activity | MYO1G MYH1 MYH2 MYH4 MYH8 ERCC2 HSP90B2P MYH13 ABCA10 HELB KIF2B STARD9 RALBP1 SHPRH HFM1 KIF5B ASCC3 LONP2 MYH7B DDX60 FIGNL2 CCT7 CHD7 CHD1L DNAH7 DNAH1 RAD50 ATP6V1H ABCB11 MACF1 MYH15 ATP2A2 | 1.48e-12 | 614 | 234 | 32 | GO:0140657 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | MYO1G MYH1 MYH2 MYH4 MYH8 MYH13 KIF2B STARD9 KIF5B MYH7B DNAH7 DNAH1 MYH15 | 1.32e-09 | 118 | 234 | 13 | GO:0003774 |
| GeneOntologyMolecularFunction | microfilament motor activity | 1.14e-08 | 38 | 234 | 8 | GO:0000146 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | MYH4 MYH8 ERCC2 HSP90B2P ABCA10 HELB KIF2B HFM1 KIF5B ASCC3 LONP2 DDX60 FIGNL2 CCT7 CHD7 CHD1L DNAH7 RAD50 ATP6V1H ABCB11 MACF1 ATP2A2 | 1.27e-08 | 441 | 234 | 22 | GO:0016887 |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | MYH4 MYH8 ERCC2 HSP90B2P ABCA10 HELB GSPT2 KIF2B HFM1 KIF5B ASCC3 EFL1 LONP2 DDX60 ARL13A FIGNL2 CCT7 CHD7 CHD1L DNAH7 RAD50 ATP6V1H ABCB11 MACF1 ATP2A2 DIRAS2 MX2 | 4.53e-07 | 775 | 234 | 27 | GO:0017111 |
| GeneOntologyMolecularFunction | pyrophosphatase activity | MYH4 MYH8 ERCC2 HSP90B2P ABCA10 HELB GSPT2 KIF2B HFM1 KIF5B ASCC3 EFL1 LONP2 DDX60 ARL13A FIGNL2 CCT7 CHD7 CHD1L DNAH7 RAD50 ATP6V1H ABCB11 MACF1 ATP2A2 DIRAS2 MX2 | 2.07e-06 | 839 | 234 | 27 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | MYH4 MYH8 ERCC2 HSP90B2P ABCA10 HELB GSPT2 KIF2B HFM1 KIF5B ASCC3 EFL1 LONP2 DDX60 ARL13A FIGNL2 CCT7 CHD7 CHD1L DNAH7 RAD50 ATP6V1H ABCB11 MACF1 ATP2A2 DIRAS2 MX2 | 2.12e-06 | 840 | 234 | 27 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | MYH4 MYH8 ERCC2 HSP90B2P ABCA10 HELB GSPT2 KIF2B HFM1 KIF5B ASCC3 EFL1 LONP2 DDX60 ARL13A FIGNL2 CCT7 CHD7 CHD1L DNAH7 RAD50 ATP6V1H ABCB11 MACF1 ATP2A2 DIRAS2 MX2 | 2.12e-06 | 840 | 234 | 27 | GO:0016818 |
| GeneOntologyMolecularFunction | actin filament binding | MYO1G MYH1 MYH2 MYH4 MYH8 MYH13 MYH7B TLN1 MACF1 MYH15 CTNNA1 CTNNA2 | 1.61e-05 | 227 | 234 | 12 | GO:0051015 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERCC2 DUS3L HELB SHPRH HFM1 ASCC3 NME1 VARS1 XRN2 TUT4 DDX60 POLR2A POLR2B SLFN12 CHD7 CHD1L RAD50 HARS2 QTRT1 QRSL1 PCNA | 2.53e-05 | 645 | 234 | 21 | GO:0140640 |
| GeneOntologyMolecularFunction | metalloendopeptidase activity | 8.59e-05 | 120 | 234 | 8 | GO:0004222 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 8.63e-05 | 62 | 234 | 6 | GO:0003678 | |
| GeneOntologyMolecularFunction | helicase activity | 1.06e-04 | 158 | 234 | 9 | GO:0004386 | |
| GeneOntologyMolecularFunction | ATP-dependent activity, acting on DNA | 1.28e-04 | 127 | 234 | 8 | GO:0008094 | |
| GeneOntologyMolecularFunction | RNA-dependent RNA polymerase activity | 4.07e-04 | 3 | 234 | 2 | GO:0003968 | |
| GeneOntologyMolecularFunction | Pyrin domain binding | 4.07e-04 | 3 | 234 | 2 | GO:0032090 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | MYO1G MYH1 MYH2 MAP9 MYH4 MYH8 MYH13 TRPM7 AGBL5 DYSF KIF2B STARD9 KIF5B NME1 ANK3 MYH7B SPAG5 TIAM1 TLN1 MACF1 MYH15 CTNNA1 CTNNA2 SKA1 PALLD MX2 | 5.30e-04 | 1099 | 234 | 26 | GO:0008092 |
| GeneOntologyMolecularFunction | metallopeptidase activity | KLK7 ADAM21 ADAM15 AGBL5 MIPEP ADAMTS15 TMPRSS6 ADAMTS12 ADAMTSL2 | 6.07e-04 | 200 | 234 | 9 | GO:0008237 |
| GeneOntologyMolecularFunction | vitamin binding | 6.37e-04 | 161 | 234 | 8 | GO:0019842 | |
| GeneOntologyMolecularFunction | caspase binding | 7.95e-04 | 16 | 234 | 3 | GO:0089720 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.09e-03 | 262 | 234 | 10 | GO:0140097 | |
| GeneOntologyMolecularFunction | insulin-like growth factor binding | 1.34e-03 | 19 | 234 | 3 | GO:0005520 | |
| GeneOntologyMolecularFunction | protease binding | 1.36e-03 | 181 | 234 | 8 | GO:0002020 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.38e-03 | 70 | 234 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | actin binding | MYO1G MYH1 MYH2 MYH4 MYH8 MYH13 TRPM7 MYH7B TLN1 MACF1 MYH15 CTNNA1 CTNNA2 PALLD | 1.63e-03 | 479 | 234 | 14 | GO:0003779 |
| GeneOntologyMolecularFunction | extracellular matrix binding | 1.66e-03 | 73 | 234 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | endopeptidase activity | KLK7 ADAM21 ADAM15 HM13 F3 MIPEP ADAMTS15 USP13 LONP2 TMPRSS6 CPS1 ADAMTS12 ADAMTSL2 | 1.76e-03 | 430 | 234 | 13 | GO:0004175 |
| GeneOntologyCellularComponent | myosin filament | 1.81e-10 | 25 | 231 | 8 | GO:0032982 | |
| GeneOntologyCellularComponent | myosin II complex | 1.79e-08 | 28 | 231 | 7 | GO:0016460 | |
| GeneOntologyCellularComponent | myosin complex | 2.69e-07 | 59 | 231 | 8 | GO:0016459 | |
| GeneOntologyCellularComponent | muscle myosin complex | 6.24e-07 | 16 | 231 | 5 | GO:0005859 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.34e-04 | 45 | 231 | 5 | GO:0044295 | |
| GeneOntologyCellularComponent | myofibril | MYH1 MYH2 MYH4 MYH8 MYH13 MYOM1 CMYA5 ANK3 MYH7B MYH15 PALLD | 2.41e-04 | 273 | 231 | 11 | GO:0030016 |
| GeneOntologyCellularComponent | cell-cell junction | MYH1 MYH2 ADAM15 ZYX SV2A FLRT1 DNMBP ANK3 NIBAN2 TIAM1 TLN1 ABCB11 DSG4 CTNNA1 CTNNA2 ATP2A2 EPHA4 | 3.27e-04 | 591 | 231 | 17 | GO:0005911 |
| GeneOntologyCellularComponent | contractile muscle fiber | MYH1 MYH2 MYH4 MYH8 MYH13 MYOM1 CMYA5 ANK3 MYH7B MYH15 PALLD | 4.03e-04 | 290 | 231 | 11 | GO:0043292 |
| GeneOntologyCellularComponent | cell leading edge | MYO1G TRPM7 DYSF ITGAV LDB1 NME1 FIGNL2 CIT TIAM1 TLN1 RAB3IP MACF1 CTNNA1 CTNNA2 PALLD | 4.75e-04 | 500 | 231 | 15 | GO:0031252 |
| GeneOntologyCellularComponent | chromosomal region | NLRP7 HJURP KIF2B BUB1 ACTL6B CTC1 POLR2B NLRP2 SPAG5 RAD50 CTCF SKA1 PCNA | 8.64e-04 | 421 | 231 | 13 | GO:0098687 |
| Domain | Myosin_N | 2.62e-10 | 15 | 234 | 7 | IPR004009 | |
| Domain | Myosin_N | 2.62e-10 | 15 | 234 | 7 | PF02736 | |
| Domain | P-loop_NTPase | MYO1G MYH1 MYH2 MYH4 MYH8 ERCC2 MYH13 NLRP7 ABCA10 NLRC4 HELB GSPT2 KIF2B STARD9 SHPRH HFM1 KIF5B ASCC3 CHST3 EFL1 LONP2 MYH7B DDX60 ARL13A FIGNL2 CHD7 CHD1L NLRP2 DNAH7 DNAH1 RAD50 ABCB11 MYH15 DIRAS2 MX2 | 5.01e-10 | 848 | 234 | 35 | IPR027417 |
| Domain | Myosin_tail_1 | 1.25e-09 | 18 | 234 | 7 | PF01576 | |
| Domain | Myosin_tail | 1.25e-09 | 18 | 234 | 7 | IPR002928 | |
| Domain | Myosin-like_IQ_dom | 1.96e-09 | 19 | 234 | 7 | IPR027401 | |
| Domain | - | 1.96e-09 | 19 | 234 | 7 | 4.10.270.10 | |
| Domain | MYOSIN_MOTOR | 1.91e-08 | 38 | 234 | 8 | PS51456 | |
| Domain | Myosin_head_motor_dom | 1.91e-08 | 38 | 234 | 8 | IPR001609 | |
| Domain | Myosin_head | 1.91e-08 | 38 | 234 | 8 | PF00063 | |
| Domain | MYSc | 1.91e-08 | 38 | 234 | 8 | SM00242 | |
| Domain | - | ERCC2 NLRP7 ABCA10 NLRC4 HELB GSPT2 SHPRH HFM1 ASCC3 CHST3 EFL1 LONP2 DDX60 ARL13A FIGNL2 CHD7 CHD1L NLRP2 DNAH7 DNAH1 RAD50 ABCB11 DIRAS2 MX2 | 2.36e-05 | 746 | 234 | 24 | 3.40.50.300 |
| Domain | Vinculin/catenin | 6.55e-05 | 7 | 234 | 3 | IPR006077 | |
| Domain | Cbl-bd_cap | 1.56e-04 | 2 | 234 | 2 | IPR003759 | |
| Domain | IQ | 1.68e-04 | 93 | 234 | 7 | PS50096 | |
| Domain | Ephrin_rec_like | 2.47e-04 | 25 | 234 | 4 | SM01411 | |
| Domain | Tyr-kin_ephrin_A/B_rcpt-like | 2.47e-04 | 25 | 234 | 4 | IPR011641 | |
| Domain | Ephrin_rec_like | 2.97e-04 | 11 | 234 | 3 | PF07699 | |
| Domain | HCY | 4.65e-04 | 3 | 234 | 2 | PS50970 | |
| Domain | - | 4.65e-04 | 3 | 234 | 2 | 3.20.20.330 | |
| Domain | S-methyl_trans | 4.65e-04 | 3 | 234 | 2 | PF02574 | |
| Domain | HCY_dom | 4.65e-04 | 3 | 234 | 2 | IPR003726 | |
| Domain | IQ | 5.38e-04 | 81 | 234 | 6 | SM00015 | |
| Pathway | KEGG_VIRAL_MYOCARDITIS | 2.50e-05 | 70 | 175 | 7 | M12294 | |
| Pathway | KEGG_TIGHT_JUNCTION | 3.91e-05 | 132 | 175 | 9 | M11355 | |
| Pubmed | Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved. | 8.41e-11 | 6 | 237 | 5 | 10077619 | |
| Pubmed | 2.93e-10 | 7 | 237 | 5 | 35210422 | ||
| Pubmed | ACLY MYEF2 MCM3AP UTP20 KIF5B ASCC3 PHIP TNPO1 RANBP2 XRN2 POLR2A COPG2 CHD7 RAD50 IGF2R CTCF TLN1 GIGYF2 MACF1 CTNNA1 ATP2A2 RPL10 | 9.76e-10 | 653 | 237 | 22 | 22586326 | |
| Pubmed | 2.10e-09 | 4 | 237 | 4 | 10388558 | ||
| Pubmed | MYH1 MYH2 MAP9 MYH4 MYH8 MYH13 NLRP7 ZSCAN26 TKTL1 CNPY2 NDUFAB1 GSPT2 TCHHL1 STARD9 BOD1L1 KIF5B NME1 VARS1 RANBP2 STIM2 UNCX MYH7B HKDC1 ADAMTS12 C2CD3 TRIM67 OGDHL MACF1 MYH15 ATP2A2 RPL10 EPHA4 | 4.70e-09 | 1442 | 237 | 32 | 35575683 | |
| Pubmed | Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro. | 1.05e-08 | 5 | 237 | 4 | 3829126 | |
| Pubmed | Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development. | 1.05e-08 | 5 | 237 | 4 | 12919077 | |
| Pubmed | 1.05e-08 | 5 | 237 | 4 | 6196357 | ||
| Pubmed | ERCC2 ACOT7 MCM10 NUAK1 XRN2 ANK3 NELFA DDX60 POLR2A SPAG5 ATP6V1H IGF2R CTCF TLN1 RAB3IP BRD9 LRCH4 MACF1 CTNNA1 CTNNA2 | 1.74e-08 | 634 | 237 | 20 | 34591612 | |
| Pubmed | ACLY GSPT2 KIF5B VARS1 STK25 TNPO1 ELOC RANBP2 POLR2B COPG2 CCT7 RAD50 HARS2 TLN1 CTNNA1 PCNA | 1.88e-08 | 399 | 237 | 16 | 37536630 | |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | MYH1 MYH2 MYH8 ERCC2 MYH13 ZYX ITPR2 NUAK1 RALBP1 BUB1 SIK2 STK25 ELOC STIM2 DPY19L1 ACAD10 RAD50 TLN1 MYH15 UBASH3B PLK4 PALLD CDK3 EPHA4 | 1.93e-08 | 910 | 237 | 24 | 36736316 |
| Pubmed | ACLY HM13 BOD1L1 KIF5B ASCC3 TNPO1 RANBP2 STIM2 ANK3 COPG2 CCT7 NIBAN2 ATP6V1H IGF2R TLN1 TCF25 GIGYF2 MACF1 CTNNA1 ATP2A2 PALLD | 2.17e-08 | 708 | 237 | 21 | 39231216 | |
| Pubmed | GPRASP1 ERBB4 HSP90B2P HM13 SNAP47 MYEF2 GSPT2 SV2A GID8 ACTL6B KIF5B NME1 ALDH9A1 VARS1 AMPD2 RANBP2 STIM2 TUT4 ANK3 CCT7 CIT TCF25 MACF1 CTNNA2 ATP2A2 DIRAS2 RPL10 | 2.19e-08 | 1139 | 237 | 27 | 36417873 | |
| Pubmed | 3.12e-08 | 6 | 237 | 4 | 1728586 | ||
| Pubmed | Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development. | 3.12e-08 | 6 | 237 | 4 | 10588881 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | ACLY MYEF2 ITPR2 UTP20 KIF5B ASCC3 PHIP VARS1 TNPO1 RANBP2 XRN2 VTN POLR2A POLR2B CCT7 CIT RAD50 IGF2R TLN1 GIGYF2 MACF1 CTNNA1 ATP2A2 RPL10 PCNA | 4.30e-08 | 1024 | 237 | 25 | 24711643 |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | ACLY ACOT7 MCM10 DUS3L MYEF2 MCM3AP A2ML1 AP1G2 UTP20 KIF5B ASCC3 ALDH9A1 PHIP VARS1 RANBP2 XRN2 POLR2A POLR2B CCT7 CHD7 CHD1L RAD50 TLN1 MACF1 KDM2A TANC1 ATP2A2 PALLD PCNA | 5.59e-08 | 1353 | 237 | 29 | 29467282 |
| Pubmed | 7.24e-08 | 7 | 237 | 4 | 16819597 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 ACLY ACOT7 CMYA5 DUS3L ZYX GSPT2 GID8 KIF5B NME1 ALDH9A1 DNMBP VARS1 TNPO1 ELOC EFL1 AMPD2 POLR2A POLR2B THUMPD1 CCT7 NIBAN2 ATP6V1H PSMG1 TLN1 MTR MACF1 CTNNA1 RPL10 PCNA | 7.52e-08 | 1455 | 237 | 30 | 22863883 |
| Pubmed | Expanding the Interactome of TES by Exploiting TES Modules with Different Subcellular Localizations. | ZYX RANBP2 DDX60 COPG2 CCT7 CPS1 ATP6V1H TLN1 MACF1 CTNNA1 CTNNA2 PALLD | 8.87e-08 | 235 | 237 | 12 | 28378594 |
| Pubmed | ACLY ZYX ITPR2 GSPT2 KIF2B UTP20 KIF5B ASCC3 SEL1L DDX60 CTCF ABCB11 GIGYF2 | 9.55e-08 | 285 | 237 | 13 | 32838362 | |
| Pubmed | ERCC2 BOD1L1 UPP1 TNPO1 ELOC EFL1 USP13 RANBP2 XRN2 NELFA POLR2A POLR2B THUMPD1 CCT7 CHD1L RAD50 PTPA CTCF PSMG1 BRD9 KDM2A QSER1 NHEJ1 PCNA | 1.44e-07 | 1014 | 237 | 24 | 32416067 | |
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDXDC1 ACLY ADAM15 HM13 TMTC3 UTP20 KIF5B ASCC3 VARS1 SEL1L TNPO1 AMPD2 RANBP2 POLR2B COPG2 SPAG5 ATP6V1H IGF2R TLN1 TCF25 MTR CTNNA1 ATP2A2 | 1.54e-07 | 942 | 237 | 23 | 31073040 |
| Pubmed | ADAM15 SYTL2 MCM10 HM13 SNAP47 ITPR2 TMTC3 BOD1L1 ALDH9A1 VARS1 TUT4 POLR2A ICA1 POLR2B CHD7 IGF2R LRCH4 MTR TANC1 QSER1 | 1.82e-07 | 733 | 237 | 20 | 34672954 | |
| Pubmed | A genome-wide association study identifies protein quantitative trait loci (pQTLs). | 1.99e-07 | 61 | 237 | 7 | 18464913 | |
| Pubmed | 2.58e-07 | 9 | 237 | 4 | 31960486 | ||
| Pubmed | PDXDC1 ERCC2 ACLY ADAM15 CNPY2 HM13 ITGAV ZYX TMTC3 BOD1L1 ALDH9A1 STK25 SEL1L TNPO1 POLR2B CCT7 PTPA ATP6V1H IGF2R PSMG1 MACF1 KDM2A CTNNA2 ATP2A2 PALLD RPL10 PCNA | 2.95e-07 | 1297 | 237 | 27 | 33545068 | |
| Pubmed | Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation. | 3.12e-07 | 3 | 237 | 3 | 26059207 | |
| Pubmed | 3.12e-07 | 3 | 237 | 3 | 36463234 | ||
| Pubmed | 4.28e-07 | 10 | 237 | 4 | 19506036 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | ERCC2 ACOT7 UTP20 KIF5B ASCC3 ALDH9A1 EFL1 RANBP2 XRN2 POGK POLR2A POLR2B THUMPD1 COPG2 CPS1 RAD50 PSMG1 RPL10 PCNA | 4.41e-07 | 704 | 237 | 19 | 29955894 |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | FOXR1 ACLY ACOT7 MYEF2 LDB1 A2ML1 UTP20 KIF5B NME1 VARS1 RANBP2 MAP3K8 POLR2A THUMPD1 CHD1L CPS1 RAD50 KDM2A QSER1 NHEJ1 PRDM15 | 5.17e-07 | 857 | 237 | 21 | 25609649 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PDXDC1 MYO1G MYH1 MYH2 MYH4 MYH8 MYH13 ACLY NME1 ELOC RANBP2 VTN MYH7B COPG2 CTNNA1 ATP2A2 RPL10 MX2 | 5.79e-07 | 647 | 237 | 18 | 26618866 |
| Pubmed | 6.68e-07 | 11 | 237 | 4 | 18310078 | ||
| Pubmed | 6.68e-07 | 11 | 237 | 4 | 8136524 | ||
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | ACLY DYSF ZYX RBMS3 ASCC3 DNMBP VARS1 TNPO1 RANBP2 TUT4 DDX60 NIBAN2 TLN1 BRD9 GIGYF2 MACF1 KDM2A ATP2A2 PALLD | 6.70e-07 | 724 | 237 | 19 | 36232890 |
| Pubmed | MYH13 ACLY OTOF VARS1 XRN2 DDX60 LINGO2 RAD50 GIGYF2 MACF1 PPIP5K1 | 7.00e-07 | 234 | 237 | 11 | 36243803 | |
| Pubmed | GPRASP1 MYEF2 LDB1 KIF5B AMPD2 RANBP2 ANK3 GRIK3 CHD7 CIT RAD50 IGF2R TRIM67 CTCF RAB3IP GIGYF2 MACF1 CTNNA1 CTNNA2 QSER1 UBASH3B EPHA4 | 8.80e-07 | 963 | 237 | 22 | 28671696 | |
| Pubmed | 1.24e-06 | 4 | 237 | 3 | 20357587 | ||
| Pubmed | 1.24e-06 | 4 | 237 | 3 | 1985022 | ||
| Pubmed | Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle. | 1.24e-06 | 4 | 237 | 3 | 11029314 | |
| Pubmed | 1.24e-06 | 4 | 237 | 3 | 22505472 | ||
| Pubmed | 1.24e-06 | 4 | 237 | 3 | 19948655 | ||
| Pubmed | Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling. | 1.24e-06 | 4 | 237 | 3 | 18417546 | |
| Pubmed | 1.24e-06 | 4 | 237 | 3 | 11023856 | ||
| Pubmed | Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles. | 1.43e-06 | 13 | 237 | 4 | 8404542 | |
| Pubmed | ACLY ACOT7 GSPT2 KIF5B ASCC3 NME1 VARS1 TNPO1 ELOC RANBP2 POLR2A POLR2B COPG2 CCT7 CIT DNAH1 ATP6V1H CTCF TLN1 CTNNA1 ATP2A2 LEF1 RPL10 PCNA CDK3 | 1.64e-06 | 1247 | 237 | 25 | 27684187 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | HSP90B2P SYTL2 BOD1L1 MYH7B DDX60 CCT7 RAD50 TLN1 LRP2 ATP2A2 | 1.85e-06 | 208 | 237 | 10 | 33230847 |
| Pubmed | 1.99e-06 | 14 | 237 | 4 | 27184118 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ACLY ACOT7 ZYX BOD1L1 KIF5B NME1 RANBP2 POLR2A GPATCH1 COPG2 CCT7 NIBAN2 SPAG5 RAD50 CTCF TLN1 GIGYF2 MACF1 PALLD RPL10 PCNA | 2.02e-06 | 934 | 237 | 21 | 33916271 |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | ERBB4 TRPM7 HJURP ZYX STARD9 SIK2 BOD1L1 KIF5B DNMBP AMPD2 STIM2 DNAH7 C2CD3 TIAM1 GIGYF2 MACF1 TANC1 PLK4 PALLD CDK3 | 2.20e-06 | 861 | 237 | 20 | 36931259 |
| Pubmed | TRIM28 functions as the SUMO E3 ligase for PCNA in prevention of transcription induced DNA breaks. | 2.71e-06 | 15 | 237 | 4 | 32900933 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | ACLY ADAM15 NAGA CNPY2 HM13 ITGAV ITPR2 MGAT5 TMTC3 UTP20 KIF5B NME1 CHST3 SEL1L STIM2 DPY19L1 SPAG5 CELSR1 IGF2R PSMG1 LRP5 CTNNA1 ATP2A2 PALLD | 2.84e-06 | 1201 | 237 | 24 | 35696571 |
| Pubmed | Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development. | 2.86e-06 | 33 | 237 | 5 | 32094117 | |
| Pubmed | PDXDC1 ACLY ACOT7 ALDH9A1 VARS1 STK25 ELOC MYH7B COPG2 CCT7 NIBAN2 PTPA ATP6V1H IGF2R TLN1 CTNNA1 QTRT1 ATP2A2 QRSL1 CDK3 | 2.94e-06 | 878 | 237 | 20 | 37223481 | |
| Pubmed | 3.05e-06 | 220 | 237 | 10 | 24550385 | ||
| Pubmed | Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections. | 3.09e-06 | 5 | 237 | 3 | 30737693 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 ACLY ACOT7 MYEF2 NME1 XRN2 ANK3 POLR2A COPG2 CCT7 NIBAN2 SPAG5 DNAH1 PTPA TLN1 MACF1 CTNNA1 ATP2A2 RPL10 | 3.28e-06 | 807 | 237 | 19 | 30575818 |
| Pubmed | A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. | 3.59e-06 | 16 | 237 | 4 | 19922871 | |
| Pubmed | ERCC2 MYEF2 UTP20 ASCC3 DNMBP VARS1 SEL1L ELOC RANBP2 LONP2 POLR2A POLR2B COPG2 CCT7 CHD7 CIT HARS2 CELSR1 CTCF TLN1 BRD9 LRCH4 MACF1 TANC1 CTNNA2 ATP2A2 RPL10 | 4.45e-06 | 1497 | 237 | 27 | 31527615 | |
| Pubmed | 4.67e-06 | 17 | 237 | 4 | 16124007 | ||
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | MAP9 VPS35L UTP20 GID8 ASCC3 NME1 ALDH9A1 SEL1L ELOC USP13 COPG2 CIT RAD50 IGF2R TCF25 INTS4 GIGYF2 QTRT1 | 4.95e-06 | 754 | 237 | 18 | 33060197 |
| Pubmed | MAP9 ANO9 HJURP DUS3L VPS35L BOD1L1 STK25 TNPO1 AMPD2 ANK3 CTC1 ICA1 POLR2B SLFN12 COPG2 CHD7 SPAG5 IGF2R LRP2 OGDHL MACF1 QSER1 | 5.90e-06 | 1084 | 237 | 22 | 11544199 | |
| Pubmed | 6.16e-06 | 6 | 237 | 3 | 20417199 | ||
| Pubmed | 6.16e-06 | 6 | 237 | 3 | 16185771 | ||
| Pubmed | A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre. | 6.16e-06 | 6 | 237 | 3 | 17559643 | |
| Pubmed | MYH1 MYH2 MYH4 MYH8 CMYA5 UPP1 NME1 RANBP2 XRN2 ANK3 COPG2 CCT7 TLN1 GIGYF2 MACF1 CTNNA1 CTNNA2 PALLD RPL10 | 6.21e-06 | 844 | 237 | 19 | 25963833 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | GPRASP1 USP18 MYH2 MYH4 GLDC SHPRH KIF5B ASCC3 NME1 ALDH9A1 VARS1 STK25 ELOC USP13 LONP2 CCT7 NIBAN2 RAD50 IGF2R GIGYF2 LONRF2 | 6.25e-06 | 1005 | 237 | 21 | 19615732 |
| Pubmed | 6.65e-06 | 102 | 237 | 7 | 10231032 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | KIF5B RMC1 DNMBP RANBP2 GPATCH1 POLR2B CCT7 DNAH7 SPAG5 RAD50 C2CD3 ATP6V1H IGF2R TLN1 LRP2 GIGYF2 TANC1 AP4M1 PCNA | 7.21e-06 | 853 | 237 | 19 | 28718761 |
| Pubmed | 7.52e-06 | 19 | 237 | 4 | 21799763 | ||
| Pubmed | ACLY GSPT2 KIF5B STK25 AMPD2 VTN CHD1L TLN1 MACF1 KDM2A CTNNA1 PCNA | 7.77e-06 | 360 | 237 | 12 | 33111431 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | NAGA ACOT7 ZYX HIBCH A2ML1 UPP1 KIF5B VARS1 TNPO1 ELOC AMPD2 RANBP2 XRN2 THUMPD1 CCT7 NIBAN2 RAD50 ATP6V1H IGF2R TLN1 CTNNA1 ATP2A2 PALLD RPL10 PCNA | 8.13e-06 | 1367 | 237 | 25 | 32687490 |
| Pubmed | ERBB4 ERCC2 TNFRSF10B MYEF2 TRIM66 SV2A MCM3AP ACTL6B ASCC3 PHIP TUT4 POGK POLR2A POLR2B RAD50 CTCF BRD9 TCF25 MTR LRP2 MACF1 TANC1 | 9.30e-06 | 1116 | 237 | 22 | 31753913 | |
| Pubmed | MCM10 ZYX SHPRH KIF5B PHIP POLR2A POLR2B CHD1L SPAG5 RAD50 C2CD3 ATP6V1H TLN1 KDM2A SKA1 PRDM15 | 1.05e-05 | 645 | 237 | 16 | 25281560 | |
| Pubmed | ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism. | 1.07e-05 | 7 | 237 | 3 | 29758057 | |
| Pubmed | BUB1 SIK2 USP13 XRN2 VTN LONP2 POGK SPAG5 LRCH4 TCF25 MTR GIGYF2 TANC1 QSER1 ZBED1 PALLD | 1.16e-05 | 650 | 237 | 16 | 38777146 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH1 MYH4 ACLY ITPR2 MCM3AP ADAMTS15 UTP20 BOD1L1 POLR2A ICA1 SLC25A16 TLN1 LRP2 OR4B1 SAMD3 LONRF2 RPL10 | 1.39e-05 | 736 | 237 | 17 | 29676528 |
| Pubmed | 1.40e-05 | 22 | 237 | 4 | 24301466 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | ACLY GSPT2 UPP1 GID8 KIF5B NME1 VARS1 ELOC AMPD2 RANBP2 LONP2 POLR2A POLR2B CCT7 CPS1 SPAG5 RAD50 TLN1 GIGYF2 MACF1 CTNNA1 ATP2A2 PALLD RPL10 PCNA | 1.46e-05 | 1415 | 237 | 25 | 28515276 |
| Pubmed | PDXDC1 ACLY CMYA5 GLDC OSBP2 KIF5B TNPO1 POLR2B COPG2 CCT7 NIBAN2 CPS1 DIRAS2 | 1.53e-05 | 451 | 237 | 13 | 36168627 | |
| Pubmed | HOXA5 plays tissue-specific roles in the developing respiratory system. | 1.54e-05 | 46 | 237 | 5 | 28827394 | |
| Pubmed | 1.71e-05 | 8 | 237 | 3 | 33667029 | ||
| Pubmed | 1.71e-05 | 8 | 237 | 3 | 20335362 | ||
| Pubmed | A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning. | 1.71e-05 | 8 | 237 | 3 | 14667415 | |
| Pubmed | 1.71e-05 | 8 | 237 | 3 | 26993635 | ||
| Pubmed | 1.71e-05 | 8 | 237 | 3 | 3864153 | ||
| Pubmed | Functional analysis of ectodermal β-catenin during external genitalia formation. | 1.71e-05 | 8 | 237 | 3 | 23480356 | |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | PDXDC1 ERCC2 ACLY HJURP HM13 KIF5B ASCC3 NME1 VARS1 STK25 ELOC RANBP2 XRN2 POLR2A POLR2B CCT7 CHD1L ATP6V1H PSMG1 MTR ATP2A2 RPL10 PCNA | 1.89e-05 | 1257 | 237 | 23 | 37317656 |
| Pubmed | 1.91e-05 | 216 | 237 | 9 | 31519766 | ||
| Pubmed | HELB BOD1L1 ASCC3 PHIP ELOC RANBP2 XRN2 DPY19L1 CHD7 RAD50 INTS4 CTNNA1 PCNA | 2.30e-05 | 469 | 237 | 13 | 27634302 | |
| Pubmed | Six1 homeoprotein drives myofiber type IIA specialization in soleus muscle. | 2.32e-05 | 50 | 237 | 5 | 27597886 | |
| Pubmed | 2.38e-05 | 25 | 237 | 4 | 38345319 | ||
| Pubmed | 2.38e-05 | 25 | 237 | 4 | 34004147 | ||
| Pubmed | Transdifferentiation of esophageal smooth to skeletal muscle is myogenic bHLH factor-dependent. | 2.55e-05 | 9 | 237 | 3 | 10725239 | |
| Pubmed | 2.55e-05 | 172 | 237 | 8 | 27375898 | ||
| Pubmed | Elongin A regulates transcription in vivo through enhanced RNA polymerase processivity. | 2.79e-05 | 26 | 237 | 4 | 33298525 | |
| Pubmed | ACLY ZYX BOD1L1 KIF5B ASCC3 ANK3 POLR2A POLR2B RAD50 TLN1 GIGYF2 KDM2A QSER1 PALLD | 2.80e-05 | 549 | 237 | 14 | 38280479 | |
| Pubmed | TRPM7 CNPY2 TNFRSF10B HM13 SNAP47 ITPR2 TMTC3 SIK2 ASCC3 ALDH9A1 TNPO1 ELOC STIM2 ANK3 POLR2B NIBAN2 IGF2R TIAM1 TLN1 MTR MACF1 TANC1 CTNNA1 ATP2A2 QRSL1 | 3.30e-05 | 1487 | 237 | 25 | 33957083 | |
| Pubmed | 3.62e-05 | 10 | 237 | 3 | 21880767 | ||
| Interaction | EED interactions | PDXDC1 HIC1 ACLY HJURP ZSCAN26 MYEF2 GLDC VPS35L SHPRH UTP20 KIF5B ASCC3 VARS1 TNPO1 ELOC RANBP2 XRN2 VTN POLR2A POLR2B CCT7 CHD7 NIBAN2 CIT RAD50 ATP6V1H IGF2R TRIM67 CTCF TLN1 MACF1 KDM2A TANC1 CTNNA1 ATP2A2 RPL10 PCNA | 3.69e-06 | 1445 | 232 | 37 | int:EED |
| Interaction | LIPA interactions | 1.22e-05 | 45 | 232 | 6 | int:LIPA | |
| Interaction | MYH6 interactions | 1.30e-05 | 94 | 232 | 8 | int:MYH6 | |
| Interaction | MOB3C interactions | ACLY GSPT2 KIF5B FAM118A VARS1 TNPO1 ELOC RANBP2 POLR2B COPG2 CCT7 HARS2 TLN1 CTNNA1 PCNA | 2.25e-05 | 364 | 232 | 15 | int:MOB3C |
| Interaction | AURKB interactions | MAP9 CMYA5 KIF5B SEL1L RANBP2 XRN2 ZFP30 CCT7 CPS1 CIT SPAG5 RAD50 PTPA TRIM67 CTCF PSMG1 GIGYF2 MACF1 UBASH3B SKA1 ATP2A2 PLK4 RPL10 | 2.51e-05 | 761 | 232 | 23 | int:AURKB |
| Interaction | KCNA3 interactions | ACLY SYTL2 HM13 BOD1L1 KIF5B ASCC3 TNPO1 RANBP2 STIM2 ANK3 MYH7B COPG2 CCT7 NIBAN2 RAD50 ATP6V1H IGF2R TLN1 TCF25 LRP2 GIGYF2 MACF1 CTNNA1 ATP2A2 PALLD | 2.60e-05 | 871 | 232 | 25 | int:KCNA3 |
| Cytoband | 17p13.1 | 3.70e-05 | 118 | 238 | 6 | 17p13.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17p13 | 9.06e-05 | 346 | 238 | 9 | chr17p13 | |
| GeneFamily | Myosin heavy chains | 1.50e-11 | 15 | 151 | 7 | 1098 | |
| GeneFamily | DNA helicases | 3.56e-04 | 17 | 151 | 3 | 1167 | |
| GeneFamily | Ferlin family | 1.02e-03 | 6 | 151 | 2 | 828 | |
| GeneFamily | NLR family | 1.15e-03 | 25 | 151 | 3 | 666 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PDXDC1 ADAM15 TNFRSF10B DUS3L DYSF ZYX WDFY2 TRIM66 PRAM1 MCM3AP KXD1 AP1G2 SEC14L1 STK25 TUT4 CTC1 MAP3K8 ICA1 NIBAN2 NLRP2 PPOX DNAH1 BRD9 LRCH4 TCF25 INTS4 KDM2A ATP2A2 RPL10 | 3.56e-09 | 905 | 236 | 29 | M40865 |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | NAGA MGAT5 GLDC SV2A AP1G2 SEC14L1 STK25 POLR2A IGF2R TCF25 LRP5 ZBED1 ATP2A2 | 1.48e-06 | 276 | 236 | 13 | M3063 |
| Coexpression | SANSOM_APC_TARGETS_REQUIRE_MYC | DUS3L MYEF2 LDB1 SHPRH BOD1L1 NME1 VARS1 NELFA CCT7 QTRT1 SKA1 | 6.75e-06 | 225 | 236 | 11 | M1757 |
| Coexpression | SANSOM_APC_TARGETS_REQUIRE_MYC | DUS3L MYEF2 LDB1 SHPRH BOD1L1 NME1 VARS1 NELFA CCT7 QTRT1 SKA1 | 8.66e-06 | 231 | 236 | 11 | MM737 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | F3 MGAT5 NUAK1 UTP20 ASCC3 DNMBP PHIP SEC14L1 CHST3 USP13 RANBP2 TUT4 POLR2B C2CD3 ATP6V1H IGF2R TIAM1 CTCF MTR GIGYF2 MACF1 EPHA4 | 1.11e-05 | 856 | 236 | 22 | M4500 |
| Coexpression | AFFAR_YY1_TARGETS_UP | 1.40e-05 | 199 | 236 | 10 | M1466 | |
| Coexpression | WANG_METHYLATED_IN_BREAST_CANCER | 1.48e-05 | 35 | 236 | 5 | M9951 | |
| Coexpression | GSE14415_ACT_TCONV_VS_ACT_NATURAL_TREG_UP | 2.75e-05 | 172 | 236 | 9 | M2945 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 2.77e-05 | 20 | 236 | 4 | M1123 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE | PDXDC1 GPRASP1 TRPM7 HELB ASCC3 RANBP2 ANK3 CTC1 LONP2 SLFN12 DNAH1 RAB3IP GIGYF2 LEF1 QRSL1 | 2.89e-05 | 474 | 236 | 15 | M40991 |
| Coexpression | AFFAR_YY1_TARGETS_UP | 2.95e-05 | 217 | 236 | 10 | MM1156 | |
| Coexpression | HUMMERICH_BENIGN_SKIN_TUMOR_DN | 3.40e-05 | 21 | 236 | 4 | MM1102 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | TNFRSF10B DUS3L ZYX WDFY2 KXD1 AP1G2 STK25 TUT4 MAP3K8 NIBAN2 GK5 DNAH1 BRD9 LRCH4 KDM2A ATP2A2 RPL10 | 6.81e-05 | 634 | 236 | 17 | M40866 |
| Coexpression | GSE3982_EOSINOPHIL_VS_BCELL_DN | 8.21e-05 | 198 | 236 | 9 | M5411 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_DN | 8.53e-05 | 199 | 236 | 9 | M9422 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_NFATC1_KOBCELL_UP | 8.53e-05 | 199 | 236 | 9 | M8255 | |
| Coexpression | GSE37416_12H_VS_24H_F_TULARENSIS_LVS_NEUTROPHIL_UP | 8.53e-05 | 199 | 236 | 9 | M5357 | |
| Coexpression | KLEIN_PRIMARY_EFFUSION_LYMPHOMA_UP | 8.64e-05 | 50 | 236 | 5 | M12993 | |
| Coexpression | GSE3982_EOSINOPHIL_VS_TH1_DN | 8.86e-05 | 200 | 236 | 9 | M5423 | |
| Coexpression | GSE39820_TGFBETA1_IL6_VS_TGFBETA1_IL6_IL23A_TREATED_CD4_TCELL_UP | 8.86e-05 | 200 | 236 | 9 | M5617 | |
| Coexpression | BHATI_G2M_ARREST_BY_2METHOXYESTRADIOL_UP | 1.22e-04 | 122 | 236 | 7 | M18550 | |
| CoexpressionAtlas | DevelopingKidney_e12.5_renal vesicle_emap-27679_k-means-cluster#2_top-relative-expression-ranked_500 | 4.68e-06 | 148 | 228 | 10 | gudmap_developingKidney_e12.5_renal vesicle_500_k2 | |
| ToppCell | mild-low-quality_cells|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | GPRASP1 ANO9 SYTL2 ALDH8A1 HELB STARD9 ANK3 CTC1 GK5 SCUBE3 SAMD3 | 9.93e-09 | 197 | 238 | 11 | e4331969bd911d1ebb5453f40a7057297b5389b4 |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 8.63e-08 | 191 | 238 | 10 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 9.06e-08 | 192 | 238 | 10 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.05e-07 | 195 | 238 | 10 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | mild-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.10e-07 | 196 | 238 | 10 | b1d9866d5dfaefdb8bedaf01a750d97987acb3d1 | |
| ToppCell | severe-T/NK_proliferative|World / disease stage, cell group and cell class | 1.15e-07 | 197 | 238 | 10 | 6b7b068b103fd4f6ceda8e01f4dd39eefc3b3633 | |
| ToppCell | 368C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.52e-07 | 154 | 238 | 9 | ba55a63cfa5e0fb9dfec794f80078a2f0d03d0ad | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4-L4_IT_VISp_Rspo1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-07 | 163 | 238 | 9 | 431221a41d396b09170476179590eaf8a55266d8 | |
| ToppCell | primary_visual_cortex-Neuronal-glutamatergic_neuron-L4|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.46e-07 | 163 | 238 | 9 | 1e8ab00ecc2d2ba35aa6745c0ed38663e26312e8 | |
| ToppCell | mild_COVID-19_(asymptomatic)-T/NK_proliferative|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 6.52e-07 | 183 | 238 | 9 | df8568751205313d149939ea2683097e3652a60b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 8.17e-07 | 188 | 238 | 9 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 8.17e-07 | 188 | 238 | 9 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.92e-07 | 190 | 238 | 9 | d19bc44310c53726e2f5f6a2bd377bbbf1d1983f | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.73e-07 | 192 | 238 | 9 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 193 | 238 | 9 | 53bcd50892c379b2a571751f6eb1062436339fe7 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 NUAK1 RBMS3 ADAMTS15 ADAMTS12 NKD1 MACF1 PALLD ADAMTSL2 | 1.02e-06 | 193 | 238 | 9 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | SVEP1 NUAK1 RBMS3 ADAMTS15 ADAMTS12 NKD1 MACF1 PALLD ADAMTSL2 | 1.02e-06 | 193 | 238 | 9 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 |
| ToppCell | control-T/NK_proliferative|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-06 | 193 | 238 | 9 | ecb4018a47d9a82bb999e0bc8b3dceabd97d1f0d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L3-5_SST_MAFB|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.02e-06 | 193 | 238 | 9 | e74fdc8718fe0933e1f4dd3fe37e2134983b99b6 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-06 | 194 | 238 | 9 | f39a471293ecc5c5967b00e772b8f48ebc9affbe | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-06 | 194 | 238 | 9 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.06e-06 | 194 | 238 | 9 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.06e-06 | 194 | 238 | 9 | a75ecd0b0a928d4646602f7d16a645f6b3df3af5 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.06e-06 | 194 | 238 | 9 | 17744fd6645cf5a447a01a83f07e8d305c2bcd9c | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 1.06e-06 | 194 | 238 | 9 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.06e-06 | 194 | 238 | 9 | e14f66f7584909621b776292fbd52808273fd2ee | |
| ToppCell | Control-Lymphoid_T/NK-T/NK_proliferative|Control / Disease group, lineage and cell class | 1.06e-06 | 194 | 238 | 9 | 9bbb124001fba7450f4639f47f9b720a483e7242 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-06 | 194 | 238 | 9 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | control-Lymphocytic-Prol._cells|control / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.06e-06 | 194 | 238 | 9 | 4c76508de3291c952386caffda2d559629ba5998 | |
| ToppCell | control-Lymphocytic-Prol._cells|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 1.15e-06 | 196 | 238 | 9 | 886f7c865b086d6ebb4a1746865c30af6bbed345 | |
| ToppCell | frontal_cortex-Neuronal|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.15e-06 | 196 | 238 | 9 | de7d10da862f98894ce47244fbc992f4a12d63bb | |
| ToppCell | severe-T/NK_proliferative|severe / disease stage, cell group and cell class | 1.15e-06 | 196 | 238 | 9 | 89f005216770dbb84378f5d1f20ca11b0ce40faa | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 1.20e-06 | 197 | 238 | 9 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | COVID-19_Severe-T/NK_proliferative|COVID-19_Severe / Disease condition and Cell class | 1.20e-06 | 197 | 238 | 9 | 718a84e9a8248080f2d964e7c6a3ba183ece9592 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.20e-06 | 197 | 238 | 9 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|World / disease group, cell group and cell class | 1.26e-06 | 198 | 238 | 9 | bf0131fbca6032e1aab4aa807f8c1d3be689cb7f | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|T/NK_cells / Location, Cell class and cell subclass | 1.26e-06 | 198 | 238 | 9 | 47d572b9db2843aeb2079f33a852babf67270be4 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-Developping_Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 198 | 238 | 9 | 2d8d4eb21b4fe3cc178b3518b3ea39c2d9650f24 | |
| ToppCell | (1)_T_cell_dividing|World / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.26e-06 | 198 | 238 | 9 | dac3a16e3a070a37f4d0ea37633c23fdc8a9c70a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_T_activated|Control / Disease, condition lineage and cell class | 1.26e-06 | 198 | 238 | 9 | ee71543559836fd59adc0da877b2ca538cba60cb | |
| ToppCell | COVID-19_Moderate-T/NK_proliferative|COVID-19_Moderate / disease group, cell group and cell class | 1.26e-06 | 198 | 238 | 9 | 166c000fb0e19602ffdd8bf2b2f19be2c6df96a6 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.26e-06 | 198 | 238 | 9 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.26e-06 | 198 | 238 | 9 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.31e-06 | 199 | 238 | 9 | 11c3d9fe811a4619347f47d2b0e94066e3085625 | |
| ToppCell | mild_COVID-19-T/NK_proliferative|World / disease group, cell group and cell class (v2) | 1.31e-06 | 199 | 238 | 9 | d44cc74d7171d96add61dae821daf774b17d4c69 | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-T_NK_proliferative|Leuk-UTI / Disease, Lineage and Cell Type | 1.31e-06 | 199 | 238 | 9 | 87113d398585076ece86b9098781e817f8ca241b | |
| ToppCell | VE-cycling|VE / Condition, Cell_class and T cell subcluster | 1.31e-06 | 199 | 238 | 9 | 47c47ebc318a0b98841ca2656837bbd068899559 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 238 | 9 | 36c80907b2ec1cbcd1b4e841e6c02a4792591d74 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 199 | 238 | 9 | 305a9ade5bbe8e981e7c641c9a5e0c9f8ef60470 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 199 | 238 | 9 | bf4c31902ae8358215245a2e11b5a2fe4ca1bc8c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.31e-06 | 199 | 238 | 9 | 101f78fe6dd1bf9e2e4dd5ad8a970312b3540927 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 238 | 9 | 7beb0e07a27fea94674f24eb61c381b0de38ed3e | |
| ToppCell | COVID-19_Mild-T/NK_proliferative|COVID-19_Mild / Disease condition and Cell class | 1.31e-06 | 199 | 238 | 9 | 9f9a88d2b099646c1e1a7ee3f8d39cb1a2498ad7 | |
| ToppCell | VE-cycling-|VE / Condition, Cell_class and T cell subcluster | 1.31e-06 | 199 | 238 | 9 | c0a67149a19b65b3069dbc5261d81f658e6e39a2 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_IN_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 1.31e-06 | 199 | 238 | 9 | f315ec3fb6c0799668c9195f836a77fc0db2b615 | |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-FOXM1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.31e-06 | 199 | 238 | 9 | 98575fcce726589e93fbb4df1aab03e57cb56076 | |
| ToppCell | normal_Lymph_Node-T/NK_cells-Undetermined|normal_Lymph_Node / Location, Cell class and cell subclass | 1.31e-06 | 199 | 238 | 9 | cefcfe639a3396bccf2354ca605a1e18b964fbf2 | |
| ToppCell | COVID-19_Mild-Lymphoid_T/NK-T/NK_proliferative|COVID-19_Mild / Disease group, lineage and cell class | 1.31e-06 | 199 | 238 | 9 | ddea0e5c1cb6a096ab8e09a8c3c37c1bff381d9c | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 238 | 9 | e0fcec796afe75e42467ca86355b9fc5aa9ae0a1 | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-Other_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.31e-06 | 199 | 238 | 9 | fba48342066aab41a8bcb20db40a6df0158e1cbe | |
| ToppCell | mild_COVID-19-T/NK_proliferative|mild_COVID-19 / disease group, cell group and cell class (v2) | 1.31e-06 | 199 | 238 | 9 | df2fcaf01b1b48632f84e7355ef21d20853f0664 | |
| ToppCell | (1)_T_cells-(1)_T_cell_dividing|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 1.31e-06 | 199 | 238 | 9 | 33afdd1b1b951b360ababf440bc556fd9e1c1db2 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Mild / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | 6126a3bbafe2110fba0c1c4493035df4e8193d22 | |
| ToppCell | control-T/NK_proliferative|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-06 | 200 | 238 | 9 | 1da366e35a05f73253629663eeea1fed4ebd7b52 | |
| ToppCell | mild-T/NK_proliferative|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.37e-06 | 200 | 238 | 9 | 25b4a1a33348e274bd4457efc0d6faa5421c3d31 | |
| ToppCell | MS-Multiple_Sclerosis-Lymphocyte-T/NK-T/NK_proliferative|Multiple_Sclerosis / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | 7faf1e37364203a08d2b2544979e848b41e36b1c | |
| ToppCell | Sepsis-URO-Lymphocyte-T/NK-T/NK_proliferative|URO / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | f277db6cc288a52a5426120c1067608700ee8ccc | |
| ToppCell | COVID-19-COVID-19_Convalescent-Lymphocyte-T/NK-T/NK_proliferative|COVID-19_Convalescent / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | 00538c4cbab5da00b3a366717d38a3ba5cfe3f65 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | 7e4c0db43a03ca11380a54f44a3cf1991e055b80 | |
| ToppCell | Sepsis-ICU-SEP-Lymphocyte-T/NK-T/NK_proliferative|ICU-SEP / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | ae500c8b7c2162cadd31bf44ee9dc3271192cf17 | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | f6b5320cdfe640a71e6e2df26f30d42e64b1c921 | |
| ToppCell | COVID_vent-Lymphocytic-Proliferative_Lymphocyte|COVID_vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | 9775ca7dedb76fcbb74f80f86b33c94e394c320a | |
| ToppCell | Control-Control-Lymphocyte-T/NK-T/NK_proliferative|Control / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | 6cf63dd57f6bc0c42e7182322dd24ff9afbe9186 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.37e-06 | 200 | 238 | 9 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | e4eb915c29909cf8535a3603c68976545c05e54b | |
| ToppCell | healthy_donor-Lymphocytic-Proliferative_Lymphocyte-|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | 415e7556b5ac45688e2c6c30a52bd40e0eb27c7d | |
| ToppCell | COVID_non-vent-Lymphocytic-Proliferative_Lymphocyte-|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 1.37e-06 | 200 | 238 | 9 | 04bf9e6a0fbd792b49eed63dabba5d6fafed8c07 | |
| ToppCell | Sepsis-Leuk-UTI-Lymphocyte-T/NK-T/NK_proliferative|Leuk-UTI / Disease, condition lineage and cell class | 1.37e-06 | 200 | 238 | 9 | 093e97395be23092229521cc55aaaee8befbc149 | |
| ToppCell | 5'-Adult-SmallIntestine-Epithelial-Tuft-related-Tuft|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.50e-06 | 168 | 238 | 8 | 8072d0496b7b730c4601009eaa69ec5366d26d73 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.66e-06 | 169 | 238 | 8 | 05e12524d68d409fed386ffad233305683b4575b | |
| ToppCell | 367C-Lymphocytic-CD4_T-cell-Proliferating_T_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.17e-06 | 172 | 238 | 8 | 8d20eda599abf1e9e3e3b90f314acddee6a465a4 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-06 | 185 | 238 | 8 | 3d6711030ca4328357b06d5497cf98cdefcd7f4f | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 7.12e-06 | 185 | 238 | 8 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Epithelial-Tuft-related|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.12e-06 | 185 | 238 | 8 | 01d0e848d8ede2745cfb10b070e2d9674ef4d477 | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 7.70e-06 | 187 | 238 | 8 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | E16.5-samps-Mesenchymal|E16.5-samps / Age Group, Lineage, Cell class and subclass | 8.01e-06 | 188 | 238 | 8 | 3f0f662be684e3a4c6652e636cc135a39a1d2790 | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 8.33e-06 | 189 | 238 | 8 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | control-Lymphocytic-Plasmablast|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 8.33e-06 | 189 | 238 | 8 | 2e4c2618d06120f83cb4887dd3497b81984a8607 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 8.33e-06 | 189 | 238 | 8 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.33e-06 | 189 | 238 | 8 | c8b8f860aaf6c73863cd79941db6b469c830ef06 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_B-plasma_cell-Plasma_cells-Plasma_cells_L.1.7.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.65e-06 | 190 | 238 | 8 | 7de42d8572599693618fb920798a2e52a0b5265c | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_PVALB_1-Inh_L2-4_PVALB_C8orf4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.65e-06 | 190 | 238 | 8 | e58e4b6fbeb4368f738adac67ec10879c0966f0f | |
| ToppCell | Int-URO-Lymphocyte-T_NK-T_NK_proliferative|Int-URO / Disease, Lineage and Cell Type | 8.65e-06 | 190 | 238 | 8 | 005967c540418b85311308072a07c684f4296aef | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 8.65e-06 | 190 | 238 | 8 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | normal_Pleural_Fluid-T/NK_cells-Undetermined|normal_Pleural_Fluid / Location, Cell class and cell subclass | 8.65e-06 | 190 | 238 | 8 | 165c61443ff0c8efbdad3b052bb00f46d81c5203 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 8.65e-06 | 190 | 238 | 8 | c3c65d1f24e0ebdbb9adb617bed299a668f423f5 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 8.65e-06 | 190 | 238 | 8 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.99e-06 | 191 | 238 | 8 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L4-6_SST_MTHFD2P6|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.99e-06 | 191 | 238 | 8 | 9c0ee270209b02043393416ecc9a81ddedfbb8b6 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.99e-06 | 191 | 238 | 8 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| Drug | SM-2 | MYH1 MYH2 MYH4 MYH8 MYH13 ACTRT3 ITGAV MYEF2 ACTL6B MYH7B SPAG5 | 1.65e-09 | 87 | 236 | 11 | CID000486033 |
| Drug | blebbistatin | MYH1 MYH2 MYH4 MYH8 MYH13 ACTRT3 ZYX ACTL6B MYH7B SLC25A16 ABCB11 | 3.55e-08 | 116 | 236 | 11 | CID003476986 |
| Drug | AC1LADJ6 | MYH1 MYH2 MYH4 MYH8 MYH13 ACTRT3 MYEF2 CBLIF ACTL6B MYH7B SPAG5 | 1.16e-07 | 130 | 236 | 11 | CID000486032 |
| Drug | fast white | 2.33e-07 | 42 | 236 | 7 | CID000024008 | |
| Drug | B0683 | 3.71e-06 | 117 | 236 | 9 | CID006398969 | |
| Drug | oxovanadium | 4.57e-06 | 120 | 236 | 9 | CID000024411 | |
| Drug | 2bq7 | 5.60e-06 | 123 | 236 | 9 | CID006540267 | |
| Drug | AC1L1GXW | 6.12e-06 | 94 | 236 | 8 | CID000003891 | |
| Drug | S-(-)-Etomoxir | 9.70e-06 | 100 | 236 | 8 | CID000060765 | |
| Drug | formycin triphosphate | 1.42e-05 | 51 | 236 | 6 | CID000122274 | |
| Drug | candesartan cilexetil | 2.12e-05 | 145 | 236 | 9 | CID000002540 | |
| Drug | AC1N9ZZC | 2.63e-05 | 149 | 236 | 9 | CID004369374 | |
| Drug | purealin | 3.00e-05 | 58 | 236 | 6 | CID006419303 | |
| Drug | Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; HL60; HG-U133A | ADAM15 ACOT7 TNFRSF10B LDB1 RBMS3 BUB1 CHD1L KCTD20 MACF1 MX2 | 3.53e-05 | 193 | 236 | 10 | 2015_DN |
| Drug | creatine | 3.53e-05 | 193 | 236 | 10 | CID000000586 | |
| Disease | distal myopathy (implicated_via_orthology) | 6.45e-15 | 12 | 233 | 8 | DOID:11720 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2B3 (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0111602 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 1 (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0111596 (implicated_via_orthology) | |
| Disease | congenital myopathy 6 (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0080719 (implicated_via_orthology) | |
| Disease | inclusion body myositis (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:3429 (implicated_via_orthology) | |
| Disease | distal arthrogryposis type 2A (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0111605 (implicated_via_orthology) | |
| Disease | autosomal dominant hyaline body myopathy (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0111269 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy 1S (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0110454 (implicated_via_orthology) | |
| Disease | familial hypertrophic cardiomyopathy (implicated_via_orthology) | 2.06e-13 | 10 | 233 | 7 | DOID:0080326 (implicated_via_orthology) | |
| Disease | myotonia congenita (implicated_via_orthology) | 1.34e-12 | 12 | 233 | 7 | DOID:2106 (implicated_via_orthology) | |
| Disease | restrictive cardiomyopathy (implicated_via_orthology) | 2.88e-12 | 13 | 233 | 7 | DOID:397 (implicated_via_orthology) | |
| Disease | distal arthrogryposis (implicated_via_orthology) | 1.07e-11 | 15 | 233 | 7 | DOID:0050646 (implicated_via_orthology) | |
| Disease | cardiomyopathy (implicated_via_orthology) | 4.98e-09 | 71 | 233 | 9 | DOID:0050700 (implicated_via_orthology) | |
| Disease | myopathy (implicated_via_orthology) | 9.78e-08 | 48 | 233 | 7 | DOID:423 (implicated_via_orthology) | |
| Disease | dilated cardiomyopathy (implicated_via_orthology) | 2.38e-07 | 80 | 233 | 8 | DOID:12930 (implicated_via_orthology) | |
| Disease | Colorectal Carcinoma | CPAMD8 ERCC2 TRPM7 LY96 ABCA10 LDB1 MCM3AP BUB1 ADAMTS15 NME1 PHIP GRIK3 PPOX TIAM1 LRP2 ABCB11 KDM2A LONRF2 LEF1 | 3.58e-06 | 702 | 233 | 19 | C0009402 |
| Disease | Lissencephaly | 9.55e-06 | 6 | 233 | 3 | C0266463 | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 3.94e-05 | 9 | 233 | 3 | EFO_0800314 | |
| Disease | glutamine measurement, amino acid measurement | 7.65e-05 | 11 | 233 | 3 | EFO_0005134, EFO_0009768 | |
| Disease | Colorectal Neoplasms | 7.72e-05 | 277 | 233 | 10 | C0009404 | |
| Disease | Van Buchem disease | 3.05e-04 | 17 | 233 | 3 | C0432272 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 3.69e-04 | 4 | 233 | 2 | EFO_0803113 | |
| Disease | gestational trophoblastic neoplasm (is_implicated_in) | 3.69e-04 | 4 | 233 | 2 | DOID:3590 (is_implicated_in) | |
| Disease | sensory peripheral neuropathy (implicated_via_orthology) | 3.69e-04 | 4 | 233 | 2 | DOID:2491 (implicated_via_orthology) | |
| Disease | Complete hydatidiform mole | 3.69e-04 | 4 | 233 | 2 | C0678213 | |
| Disease | leucine-rich repeat transmembrane neuronal protein 1 measurement | 3.69e-04 | 4 | 233 | 2 | EFO_0020531 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMVEREVPSDTRLGF | 71 | Q86Y25 | |
| RVERTDFLSPMCIGE | 106 | O00154 | |
| FEKAMAVGATECISP | 241 | P40394 | |
| CSLLSSGDKPEAVMV | 751 | Q8NDL9 | |
| RACPSSKMEVEENGI | 306 | Q15303 | |
| MEIEVSVAECKSVPG | 1 | Q9Y2D5 | |
| IKDESCCMTEEIFGP | 381 | Q9H2A2 | |
| CRDDMTCVKEEIFGP | 381 | P49189 | |
| VRKMFEPFGTIDECT | 111 | Q5SZQ8 | |
| CEENMVVPSRDGKFS | 641 | O43683 | |
| TPMLFEKDGSSCISR | 826 | Q2NKJ3 | |
| EVSKEGLAESEPMIC | 141 | P49711 | |
| ITDMEEIRKNIGFCP | 461 | Q8WWZ4 | |
| KPSREVISCMFEPEG | 271 | Q9H8M2 | |
| LEAPGIDKICFSSIM | 266 | Q9BYD9 | |
| APAKTCIMEASTDFL | 371 | Q13444 | |
| TQFPAMRCGLTEKEV | 166 | Q9UKJ8 | |
| KSPLAGDFISMQCRE | 191 | O94805 | |
| MACGATLKRTLDFDP | 1 | Q53H80 | |
| PFSGQLIATMKEACR | 956 | Q7Z2Z2 | |
| FGFEIPDIDAEKLMC | 126 | O14561 | |
| DVDDPMVSQGLRCLK | 1111 | A8K2U0 | |
| GSAEMCRDLAPEVEK | 131 | O75843 | |
| GRLCSEMLKTSVPVD | 106 | Q6JQN1 | |
| TIDRKPIIDCMSEDG | 396 | O95342 | |
| FVKLCPDTRVEETMA | 296 | Q6XZF7 | |
| SVTFALDEPMKEGEC | 261 | Q5H913 | |
| MENRLKPFFTCGSAD | 216 | P21854 | |
| DCDTTMAVRFGKDIG | 1561 | Q9NYQ6 | |
| LEGAFPDTMTKCAEL | 366 | Q96G46 | |
| FPLDLRTSMDGKCKE | 111 | Q01433 | |
| ALKLCDFEMPRTFSE | 401 | A1A5B4 | |
| CFLERVGMPDAKAIA | 1816 | Q9P2D1 | |
| ASLMLPESEGEFCRK | 191 | Q8IUH2 | |
| FTEAFCRDKMNSPGL | 1421 | O14578 | |
| EKMLDAVIDGTPCFE | 646 | P58397 | |
| GTMCDPKRSCSVIED | 336 | Q8TE58 | |
| PSGSEMRIGLTEEFC | 221 | O00189 | |
| GTVLPEFEKCLTMRD | 271 | P16260 | |
| VPLCIGVSTDKASME | 601 | Q8NCD3 | |
| DEKKMERVSEPCPGS | 101 | Q969G9 | |
| KELMPRFEEACGRTT | 281 | Q15311 | |
| GGTEVMVPSFCKSEE | 2781 | P49792 | |
| GVGFARMESTEKCEV | 181 | Q6XE24 | |
| DEPTMDRTCPFLDKI | 326 | Q96QF0 | |
| GSMCFPEAVLLSDER | 831 | Q2KHR3 | |
| GTIMPEEESAKVCLT | 776 | Q92878 | |
| KTAGFSPDCIMDDAI | 101 | Q96HW7 | |
| DTDEERPVMLKIGTC | 406 | Q14571 | |
| FRVATEKCLFAMPET | 156 | Q6NVY1 | |
| EKCLFAMPETAIGLF | 161 | Q6NVY1 | |
| DSKVEGPAFTDAIRM | 201 | Q96TA1 | |
| KGCTERFVCSPDEVM | 166 | P33176 | |
| ELCATDEMIPFKDEG | 16 | Q9UJU2 | |
| SFLEACRKMGVPEAD | 606 | O75427 | |
| RVCSEEGPPKTDLMA | 756 | Q9Y5I1 | |
| RCVFITDDFRDTMPK | 71 | Q58FF3 | |
| EEFPNTCKMREELGE | 131 | Q86WA8 | |
| MAPDGCEDIVVKSFS | 116 | Q49MG5 | |
| DAMLTITFCLEDGPK | 101 | Q86U70 | |
| EKVGECEASAMLPLE | 126 | Q9H3P2 | |
| EGMDYIVKSLSSEPC | 806 | Q9NPP4 | |
| QCMLRVLDSFGTEPE | 371 | Q09328 | |
| MTFPEADILLKSGEC | 1 | Q14526 | |
| IMPLAEDIKGSCFQS | 71 | Q7Z5Y7 | |
| RTFVGTCLDMCPEKE | 631 | O60318 | |
| CIDGSDELMCEITKP | 1361 | O75197 | |
| FCPGESSRMGIKDRI | 426 | P56696 | |
| LMSCKEGRVAISPFV | 1576 | Q8IY21 | |
| SCMETLDPKFRTLAE | 831 | Q86SJ6 | |
| KVSDFGMSRVLEDDP | 761 | P54764 | |
| LEKLESCGPMREFEI | 216 | P41279 | |
| TICLETFKDFPQMGR | 591 | Q8IYD1 | |
| GQKDALERCLDPSMT | 526 | Q9BRR8 | |
| LSILEEECMFPKASD | 576 | A7E2Y1 | |
| LGIFSILEEECMFPK | 531 | P13535 | |
| ILEEECMFPKATDTS | 536 | P13535 | |
| VVKMPSGEFARICRD | 136 | P12004 | |
| MDLPDSASRVFCGRI | 1 | Q9BQD3 | |
| SEKRFGLEGCEVMIP | 261 | Q9ULD0 | |
| AACIELIEKPMGIFS | 521 | Q9UKX2 | |
| ILEEECMFPKATDTS | 536 | Q9UKX2 | |
| EAEGTCLRFSPLMTA | 451 | Q6P996 | |
| VMDLEAEGTCLRFSP | 446 | Q6P474 | |
| CAAEFDFMEKETPLR | 391 | Q2PZI1 | |
| DVTFPSDLMCVDVKL | 156 | P49862 | |
| LMVPARDGTSCKLTD | 161 | Q86TH1 | |
| SCMDASLAIKPVFER | 436 | P18074 | |
| MCAGPDTIRERSFKD | 381 | Q7L985 | |
| RCARGKNASDMPETI | 56 | Q8TCT9 | |
| AACIELIEKPMGIFS | 521 | P12882 | |
| ILEEECMFPKATDTS | 536 | P12882 | |
| AKELEATFGCRMSPD | 566 | Q9NX02 | |
| ATFGCRMSPDIKQEL | 571 | Q9NX02 | |
| FTSMSDRPGKRCAAE | 4036 | P98164 | |
| GCMLEIKDVRTFPDG | 591 | Q1L5Z9 | |
| SEEFKELMDLPTCGA | 516 | Q7L590 | |
| CREGKVFAASTVPMT | 191 | A6NLU0 | |
| LEDGPADMQKVRICS | 26 | Q9P215 | |
| FEKRLDPLTGEMACV | 881 | Q969R2 | |
| EFGCKDQRKPRMSSD | 2851 | Q9UPN3 | |
| PEEIKLFTSSAMCRD | 401 | Q5TIA1 | |
| SDGERPAVCLKMDES | 471 | A2PYH4 | |
| KIFEGMPVTFTCRVA | 1011 | Q8WX93 | |
| MAATFFGEVVKAPCR | 1 | O95456 | |
| CAMISTSIGEEFELP | 2141 | Q8NFC6 | |
| CIFAEMVTRKALFPG | 191 | Q00526 | |
| ERQGLSPKEAMLCFI | 236 | Q8N878 | |
| SMENAIRFGKPCLLE | 3266 | Q9P2D7 | |
| RTGDAKPSFFQDCLM | 101 | Q9NWS6 | |
| MFVKGAPEGVIDRCT | 511 | P16615 | |
| ADPILRCEMASTGEV | 1321 | P31327 | |
| IMALTSSCRDPGDKV | 96 | P27352 | |
| PDFTVNDVKMCVGSR | 91 | Q9Y2K7 | |
| VNCRFGPDTSLKTME | 206 | Q9H2M3 | |
| GPFCREELMVKSSFL | 2116 | Q4AC94 | |
| ADDPCSSVKRGTMVR | 111 | P26232 | |
| FADDPCSSVKRGNMV | 111 | P35221 | |
| RACDESFQPLGDIMK | 571 | Q6Y7W6 | |
| SMDVPGILTRCVDDA | 226 | Q9H0R6 | |
| IMLVGNKCDESPSRE | 116 | Q96HU8 | |
| PATMFLRTTKEECEL | 386 | Q8N3K9 | |
| LGSRDFDICVRDMIP | 291 | Q8IZJ3 | |
| TEMKQEREPVGTCFL | 146 | P06756 | |
| KEEMQRFAPGLSCVT | 111 | Q86WJ1 | |
| CDRMKEYGEQIDPST | 86 | Q9Y2B0 | |
| LMFEGTELKLDPTCA | 1411 | Q8WXX0 | |
| CFRDSFEKVPVSMQG | 226 | Q6PIV2 | |
| AEKFRMESGIEPSVD | 46 | Q9NWU2 | |
| VFAKMNDPVESSLRC | 1316 | Q12955 | |
| IITFLGMQPCERSDK | 801 | Q9UBF2 | |
| CEGPDAMYVKLISSD | 11 | Q15369 | |
| LSIAGCPKITDSAME | 611 | Q8NEE6 | |
| YKCVVEAISGSPEEM | 131 | Q9Y6Y9 | |
| KFPVGRRDFDTLSCM | 61 | Q16048 | |
| MAKSLEDSEGVCFVP | 361 | Q6ZS86 | |
| DPGALELVTSKMVDC | 371 | A6NMB9 | |
| VCFVETDGRGKMIPE | 236 | Q6ZQY3 | |
| KDITSEMDECFETGP | 341 | Q9NZU1 | |
| TFNDRRLPGKDSMAC | 896 | Q13003 | |
| PIEDECGDVLVMRKS | 846 | Q8IWY4 | |
| SMVESPLICKEGESV | 606 | Q92503 | |
| LPSEDECGDVLVMRK | 851 | Q8IX30 | |
| GMRSPKLEECEEAFT | 46 | W5XKT8 | |
| VDPFVEVSFAGKMLC | 416 | O75923 | |
| CGVNDDESPSKIFMV | 1041 | Q8NG08 | |
| AMKTSLGVPQCERDE | 111 | P0C7A2 | |
| PLVESIFRKGMATCF | 286 | Q8N4N8 | |
| ATPISESCAGKMEEF | 596 | Q9HC10 | |
| TACSGPIDELLDMKS | 336 | Q05084 | |
| PLFKLACTDTFMEGV | 181 | Q8NGF8 | |
| KREACIDFMPGSIDV | 336 | Q5JY77 | |
| SMGTPKLLRTSECDF | 1771 | P11717 | |
| GFRPEDLMEACVELT | 851 | Q9HCH5 | |
| DRACFTMDPKLSAAV | 441 | P26640 | |
| SPSRMKAFIRCVGAE | 61 | Q16831 | |
| KSSGECVLEMLDPFV | 2101 | O75691 | |
| CREGKVFAASTVPMT | 191 | F8VTS6 | |
| DCEFIQRFEMKRSPE | 46 | Q9UI12 | |
| MFAVCGVPESKFRAI | 221 | P49590 | |
| REEVAPCMGDRFSEV | 171 | Q96R06 | |
| EDPARSCMEGKSFLQ | 36 | Q99624 | |
| ATCLEEMTKRDVPGF | 211 | Q9BXR0 | |
| QRSIKEMPFITCDEF | 131 | Q96BD8 | |
| VSMTSCEPFGKEGIL | 241 | Q5SQN1 | |
| AAREMFEKLTEEGSP | 241 | Q9UBV2 | |
| ETVKELAPRCDVTFM | 876 | Q2TB90 | |
| LAPRCDVTFMLSEDG | 881 | Q2TB90 | |
| SPESAEKACRIMNGI | 571 | Q9P2K5 | |
| MANCERTFIAIKPDG | 1 | P15531 | |
| FEDMVAEKRLIPDGC | 181 | P27635 | |
| KMTATCLLLPDVFGD | 401 | Q8N6K7 | |
| GILSILEEECMFPKA | 541 | Q9Y2K3 | |
| LEEECMFPKATDLTF | 546 | Q9Y2K3 | |
| GIREAGCRKDMPVSE | 286 | P57071 | |
| DKFFRMEPSEITNGC | 486 | Q8NE18 | |
| EMRPFIEIIGKCTTA | 266 | Q99707 | |
| FRVIDLGVMTPCDKI | 801 | Q99707 | |
| FTSNEEMLCRDPKGK | 621 | Q96QH2 | |
| AAMTELKSCRDGLQP | 61 | P0DMR2 | |
| EEVFEKPTRETCQGM | 826 | P30876 | |
| AFMEEECVDTPKVNG | 411 | Q9H0K1 | |
| EPMSICDKGILVESS | 166 | Q149N8 | |
| SDKQGRTPLMVAACE | 1141 | Q9C0D5 | |
| RDMFCAGRVPEEDLK | 306 | Q99832 | |
| AACIELIEKPMGIFS | 521 | Q9Y623 | |
| ILEEECMFPKATDTS | 536 | Q9Y623 | |
| SRMGPCSFAELISKD | 216 | Q8WX94 | |
| AKELEATFGCRMSPD | 531 | Q8WX94 | |
| ATFGCRMSPDIKQEL | 536 | Q8WX94 | |
| EQFMIEKLPEACSIG | 191 | Q9H9Q4 | |
| PSTFKMEQDLCRTGV | 426 | O60285 | |
| CRKPGLMTSSDEDFF | 1636 | Q9P2P6 | |
| KCILMENSPGADFEV | 711 | O00444 | |
| SPMKKFRECSRIFGE | 226 | A4IF30 | |
| LGKMVPSFCSDAEDI | 826 | Q4LDE5 | |
| SLAEESCPGISDKLM | 391 | O00506 | |
| VGFVLPSAEKDMCLS | 186 | Q7L0J3 | |
| KPASFMTSICDERGQ | 836 | P53396 | |
| EDLEVSEGLMCFDPK | 356 | Q8N3C0 | |
| SEGLMCFDPKELRIQ | 361 | Q8N3C0 | |
| MEKGLTLPQDCRDFV | 1 | Q7LGC8 | |
| ESPFIMFISKGSCEV | 276 | Q96M20 | |
| PEVASLAMDSLCRGV | 156 | P50336 | |
| MEEELKCPVCGSLFR | 1 | Q6ZTA4 | |
| MATLVFSRSCKPEEG | 486 | A0A0J9YY54 | |
| MERIKSCGLEEQESP | 106 | Q9Y2G7 | |
| DFIGMIKECDESGFP | 446 | Q7Z3J2 | |
| SIPLMGFEFEVRVCD | 331 | Q96P53 | |
| NPTRKMLDCISEEVG | 1881 | Q9C0A1 | |
| KDCEEARGMETRASP | 206 | Q13009 | |
| EGMLQKCPSVDDFVS | 681 | Q99797 | |
| ESPMELCKDVRLIFS | 1376 | Q8WWQ0 | |
| PISFRMDDKGEVKCI | 56 | Q96DM3 | |
| PDCVGLTETKSMIFS | 651 | Q9P246 | |
| CILFITEMKTGPFAE | 291 | Q15257 | |
| MRDKAPGQLECETAI | 1651 | Q9Y490 | |
| KRISDEECFVLGMEP | 226 | P24928 | |
| RQDTGPLMKCSFEET | 1421 | P24928 | |
| TPGTEFMDNLAKCLR | 161 | Q9H0D6 | |
| IEKPMGIFSILEEEC | 526 | Q9UKX3 | |
| GIFSILEEECMFPKA | 531 | Q9UKX3 | |
| CEEMDSVRKGSLIFS | 411 | Q8IYM2 | |
| LDTPKLDCFLSGMEA | 41 | O95947 | |
| EGTFREEDSPEMCRK | 141 | O14763 | |
| DSPVECMGQEKGEFR | 236 | P13726 | |
| EEKDSAFRGICTMIS | 816 | Q92973 | |
| CGRVESSGKISEPME | 196 | Q16670 | |
| FSQILPMKRESCDAE | 281 | Q3LFD5 | |
| LEKCNTCGEPITDRM | 441 | Q15942 | |
| TFGNSEKPETMTCRL | 126 | Q9BQ24 | |
| FSQILPMKRESCDAE | 281 | Q9UMW8 | |
| EKDAPITVFGCMQAR | 436 | Q8TF42 | |
| DVCRMFDTQEPGKDA | 326 | Q5QJ38 | |
| LSMGSRCLKTFEVPE | 226 | O96006 | |
| GAKKCFERILEMDPS | 756 | Q6ZXV5 | |
| RLKICAASSGEMPVF | 866 | O15016 | |
| EEMSKVITTFLPECS | 381 | Q5TAX3 | |
| TCMRADSSKGFLERP | 296 | Q96IQ7 | |
| SLTSEDGRIKCMFFP | 306 | Q6NT04 | |
| AECKPQVTRGDVFTM | 56 | P04004 | |
| MSFLEKRGCPRTALE | 351 | Q9BQ70 | |
| EDIAMFRTIPKCTIF | 406 | P51854 | |
| IKAEEKRSCDMVFGP | 1781 | Q96QT4 | |
| LAEMGFPLEACRKAV | 661 | Q92995 | |
| RMLPISGTCKAFLED | 161 | Q9NXG2 | |
| CGFRPASSENEEMKT | 926 | Q6PFW1 | |
| AEPEGMFKACEDSKR | 31 | Q8IU80 | |
| TCSGEPMDPEEIARK | 181 | A6NJT0 | |
| GVLTELKLPCEMDFS | 241 | P23378 | |
| RCGADIPSQEADKMF | 406 | P20592 | |
| QLCPTDKTMEFGRDF | 501 | B0I1T2 | |
| DMLKLDGCFSTPEER | 151 | P17050 | |
| DGVISLNFECDKMTP | 1151 | P52179 |